心舒寧膠囊聯(lián)合康復(fù)訓(xùn)練治療老年慢性心力衰竭的臨床研究
發(fā)布時間:2018-09-13 08:59
【摘要】:目的觀察心舒寧膠囊聯(lián)合康復(fù)訓(xùn)練治療老年慢性心力衰竭的臨床療效及安全性。方法將99例慢性心力衰竭老年患者隨機分為對照組46例和試驗組53例。對照組予以運動康復(fù)訓(xùn)練;試驗組在對照組治療的基礎(chǔ)上,予以心舒寧膠囊每次2.0~3.2 g,tid,口服。2組患者均治療8周。比較2組患者的臨床療效、心功能指標(biāo),以及藥物不良反應(yīng)的發(fā)生情況。結(jié)果治療后,試驗組和對照組的總有效率分別為90.57%(48例/53例)和71.74%(33例/46例),差異有統(tǒng)計學(xué)意義(P0.05)。治療后,試驗組和對照組的左心室收縮末期內(nèi)徑分別為(31.94±4.68)和(38.85±4.01)mm,左心室舒張末期內(nèi)徑分別為(47.21±7.81)和(54.58±7.75)mm,左心室心肌重量指數(shù)分別為(58.84±4.73)和(52.37±5.01)g·m~(-2),左心室射血分?jǐn)?shù)分別為(49.91±6.95)%和(44.23±5.29)%,左心房內(nèi)徑分別為(34.34±6.27)和(40.32±6.52)mm,差異均有統(tǒng)計學(xué)意義(均P0.05)。2組患者發(fā)生的藥物不良反應(yīng)以頭痛、胃腸道反應(yīng)、皮疹為主,且試驗組和對照組的藥物不良反應(yīng)發(fā)生率分別為5.66%和10.87%,差異無統(tǒng)計學(xué)意義(P0.05)。結(jié)論心舒寧膠囊聯(lián)合康復(fù)訓(xùn)練治療老年慢性心力衰竭的臨床療效顯著,其能顯著改善患者的心功能,且不增加藥物不良反應(yīng)的發(fā)生率。
[Abstract]:Objective to observe the clinical efficacy and safety of Xinshuning capsule combined with rehabilitation training in the treatment of senile chronic heart failure. Methods 99 elderly patients with chronic heart failure were randomly divided into control group (n = 46) and trial group (n = 53). The control group was given exercise rehabilitation training, and the experimental group was treated with Xinshuning capsule for 8 weeks on the basis of the treatment of the control group. The clinical efficacy, cardiac function index and adverse drug reaction were compared between the two groups. Results after treatment, the total effective rates of the experimental group and the control group were 90.57% (48 / 53) and 71.74% (33 / 46), respectively. The difference was statistically significant (P0.05). After treatment, The left ventricular end-systolic diameter of the trial group and the control group were (31.94 鹵4.68) and (38.85 鹵4.01) mm, respectively (47.21 鹵7.81) and (54.58 鹵7.75) mm,. The left ventricular mass index was (58.84 鹵4.73) and (52.37 鹵5.01) g m-2, and the left ventricular ejection fraction was (49.91 鹵6.95)% and (44.23 鹵5.29), respectively. (34.34 鹵6.27) and (40.32 鹵6.52) mm, respectively (P0.05). The incidence of adverse drug reactions in the experimental group and the control group was 5.66% and 10.87 respectively with no significant difference (P0.05). Conclusion Xinshuning capsule combined with rehabilitation training is effective in the treatment of elderly patients with chronic heart failure. It can significantly improve the heart function of the patients and does not increase the incidence of adverse drug reactions.
【作者單位】: 遼寧醫(yī)藥職業(yè)學(xué)院康復(fù)教研室;遼寧中醫(yī)藥大學(xué)第一臨床學(xué)院心內(nèi)科;河北醫(yī)科大學(xué)第二醫(yī)院心內(nèi)科;
【基金】:河北省科學(xué)研究重點課題計劃基金資助項目(ZL20140073)
【分類號】:R541.6
本文編號:2240678
[Abstract]:Objective to observe the clinical efficacy and safety of Xinshuning capsule combined with rehabilitation training in the treatment of senile chronic heart failure. Methods 99 elderly patients with chronic heart failure were randomly divided into control group (n = 46) and trial group (n = 53). The control group was given exercise rehabilitation training, and the experimental group was treated with Xinshuning capsule for 8 weeks on the basis of the treatment of the control group. The clinical efficacy, cardiac function index and adverse drug reaction were compared between the two groups. Results after treatment, the total effective rates of the experimental group and the control group were 90.57% (48 / 53) and 71.74% (33 / 46), respectively. The difference was statistically significant (P0.05). After treatment, The left ventricular end-systolic diameter of the trial group and the control group were (31.94 鹵4.68) and (38.85 鹵4.01) mm, respectively (47.21 鹵7.81) and (54.58 鹵7.75) mm,. The left ventricular mass index was (58.84 鹵4.73) and (52.37 鹵5.01) g m-2, and the left ventricular ejection fraction was (49.91 鹵6.95)% and (44.23 鹵5.29), respectively. (34.34 鹵6.27) and (40.32 鹵6.52) mm, respectively (P0.05). The incidence of adverse drug reactions in the experimental group and the control group was 5.66% and 10.87 respectively with no significant difference (P0.05). Conclusion Xinshuning capsule combined with rehabilitation training is effective in the treatment of elderly patients with chronic heart failure. It can significantly improve the heart function of the patients and does not increase the incidence of adverse drug reactions.
【作者單位】: 遼寧醫(yī)藥職業(yè)學(xué)院康復(fù)教研室;遼寧中醫(yī)藥大學(xué)第一臨床學(xué)院心內(nèi)科;河北醫(yī)科大學(xué)第二醫(yī)院心內(nèi)科;
【基金】:河北省科學(xué)研究重點課題計劃基金資助項目(ZL20140073)
【分類號】:R541.6
【相似文獻(xiàn)】
相關(guān)期刊論文 前5條
1 周爾鳳;心舒寧[J];山西醫(yī)藥雜志;1979年06期
2 ;心舒寧注射液[J];武漢新醫(yī)藥;1974年01期
3 馬曉偉;李昊;張幼怡;;運動康復(fù)訓(xùn)練對心血管疾病的保護(hù)作用及相關(guān)機制研究進(jìn)展[J];中國醫(yī)學(xué)前沿雜志(電子版);2013年09期
4 李明娥;王梅林;霍紅梅;;運動康復(fù)訓(xùn)練對老年慢性心力衰竭患者預(yù)后的影響[J];山東醫(yī)藥;2010年29期
5 鄧錦清;劉澤;郭振輝;戴波;;康復(fù)訓(xùn)練對老年冠心病慢性心力衰竭患者心功能及預(yù)后的影響[J];廣西醫(yī)學(xué);2014年08期
相關(guān)重要報紙文章 前1條
1 武漢協(xié)和醫(yī)院副主任醫(yī)師 張敏;心衰患者康復(fù)訓(xùn)練要點[N];家庭醫(yī)生報;2009年
,本文編號:2240678
本文鏈接:http://sikaile.net/yixuelunwen/xxg/2240678.html
最近更新
教材專著